Usamos cookies propias y cookies de terceros para recoger información sobre sus visitas y el uso que realiza de nuestra web. En caso de continuar navegando por esta web entenderemos que acepta el uso de estas cookies. Más información:Política de Cookies.
Faculty of Medicine and Health Sciences. University of Barcelona
Barcelona Global Health Summer School 2017: Innovation, Access & Health
The World Health Organisation considers equitable access to effective, safe and affordable drugs, diagnostic devices and preventive toolssuch as vaccines as vital to the attainment of the highest possible standard of health by all, i.e.: the right to health. It is also a key component of the Sustainable Development Goal number 3, that proclaims “Health for All” as the shared vision of the international community to be reached in 2030. Furthermore, access to treatment is a cornerstone of Universal Health Coverage, without which households risk to be impoverished when facing catastrophic health-related expenditures.
Despite that, large parts of the world population do not have access to the tools that will prevent them from being ill, or progress in their diseases, or even die. This could be because either the quality medicines they need exist but are not affordable or accessible to them, or because the disease they experiment has no treatment as it has been neglected by the current research & development model.
The Barcelona Global Health Summer School 2017 will gather key experts in the field to address the causes, contexts, and consequences of the inequitable access to medicines and what to do about it.
BGHSS 2017 Programme
Sunday, 16 July 17:30 – 19:00 Welcome Reception
Monday, 17 July 09.00 – 10:45 - Innovation, Access and the Health Systems Hans Hogerzeil, The Lancet Commission on Essential Medicines. Geneva. 10:45 – 11:15 - Coffee Break 11:15 – 13:00 - The Bottleneck: Health Technology Assessment Valentina Strammiello, European Patients’ Forum. Brussels. 13:00 – 14:00 - Lunch 14:00 – 15:45 - Who Pays What? Drug Pricing & Reimbursement Models Natàlia Pasqual, UPF Barcelona School of Management. 15:45 – 16:15 - Break 16:15 - 18:00 - Participant Project Development Case Studies by Adrián Alonso and José Cerezo, Barcelona Master Global Health.
Tuesday, 18 July 09:00 – 10:45 Public-Private Partnerships: Angel or Devil? Carolina Bolaños, Master of Global Health. Barcelona / San José de Costa Rica. 10:45 – 11:15 - Coffee Break 11:15 – 13:00 - Measuring Access to Treatment Clarke Cole, Access to Medicines Foundation. Amsterdam. 13:00 – 14:00 - Lunch 14.00 - 15.45 - Trade agreements & Access to Medicines Jaume Vidal, Health Action International. Amsterdam. 15:45 – 16:15 - Break 16:15 - 18:00 - Participant Project Development
Wednesday, 19 July 09:00 – 10:45 - The current R&D model and its alternatives Elena Villanueva, MSF Access Campaign. Geneva. 10:45 – 11:15 - Coffee Break 11:15 – 13:00 - Product Development Partnerships: Pros & Cons Joan Tallada, Barcelona Institute for Global Health. 13:00 – 14:00 - Lunch 14:00 – 15:45 - Access, Challenges: The Viral Hepatitis Case Jeffrey Lazarus, Barcelona Institute for Global Health / University of Copenhagen 15:45 – 16:15 - Break 16:15 - 18:00 - Participant Project Development
Thursday, 20 July 09:00 – 10:45 - R&D Challenges: The Antimicrobial Resistance Case Clara Ballesté, Barcelona Insitute for Global Health. 10:45 – 11:15 - Coffee Break 11:15 – 13:00- Campaigning for a New R&D Model Irene Bernal, Right to Health Foundation. Madrid. 13:00 – 14:00 - Lunch 14:00 – 17:00 - Participant Projects Facilitator: AECS-IFMSA
Afternoon: 17.15-20:00 - Visit to Science Museum "CosmoCaixa"
20:30 – Group Dinner
Friday, 21 July 10:00 – 12:00 Participants Projects
12:00 - 13:00 Closing Session: Reports, Diplomas, Final Words and Group Photo.
We have reached the maximum number of applications available and registration is now closed. However, you can still send your candidacy to be included in the waiting list.
Applications meeting the required profile are accepted on a first-come, first-served basis until maximum number of participants is reached. Candidates will be notified of acceptance by email. Maximum number of participants: 60